Friday 16 October 2026
Export CDXS’s income statement to Excel — free account
Codexis, Inc.
CDXS Healthcare Biotechnology
Codexis, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $70.4 million, up 18.6% from fiscal 2024. In the quarter to June 2026, revenue fell 2.69%, EPS grew 18.8%, free cash flow grew 48.6% and total debt fell 14.1%, each against the same quarter a year earlier.
1.25
0.11
−8.09%
Follow CDXS
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 5 | 4 | 3 |
+8 more TTM periods Free account |
| (69.36%) | (68.90%) | (74.88%) | (114.26%) | ||
| (23.79%) | (24.77%) | (29.63%) | (47.00%) | ||
ROIC |
(151.17%) | (100.87%) | (218.36%) | (195.29%) | |
Return on Tangible Assets |
(50.94%) | (41.34%) | (52.03%) | (89.16%) | |
Average Days of Receivables |
34.33 | 35.46 | 52.86 | 52.43 | |
Free Cash Flow per Share |
(0.13) | (0.24) | (0.27) | (0.68) | |
Free Cash Flow |
(12.16) | (22.11) | (23.84) | (61.65) | |
Capital Expenditures |
(1.76) | (3.39) | (4.47) | (5.72) | |
| Other line items | |||||
Cash ROIC |
(9.96%) | (14.81%) | (14.08%) | (44.85%) | |
Accounts Receivable Turnover |
6.90 | 8.98 | 5.70 | 5.11 | |
Accounts Payable Turnover |
4.95 | 2.12 | 4.25 | 3.30 | |
Inventory Turnover |
5.69 | 4.59 | 5.16 | 5.42 | |
Average Days of Payables |
94.44 | 89.55 | 60.74 | 80.84 | |
Days of Inventory on Hand |
57.99 | 84.20 | 71.02 | 64.54 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
62.75% | 65.07% | 74.31% | 99.53% | |
Selling, General and Administrative Expense of Revenue |
55.50% | 56.98% | 66.88% | 92.45% | |
Share Based Compensation of Revenue |
9.94% | 11.11% | 13.67% | 18.80% | |
Interest Coverage |
(5.05) | (5.68) | (8.67) | (8.30) | |
Operating CF/Net income |
0.34 | 0.59 | 0.44 | 0.87 | |
Depreciation/Fixed assets |
0.64 | 0.59 | 0.54 | 0.49 | |
Capex/Depreciation |
(0.23) | (0.45) | (0.63) | (0.84) | |
Revenue per Share |
0.85 | 0.86 | 0.81 | 0.59 | |
Operating CF per Share |
(0.11) | (0.21) | (0.22) | (0.62) | |
Capex per Share |
(0.02) | (0.04) | (0.05) | (0.06) | |
Capex to Sales |
0.02 | 0.04 | 0.06 | 0.11 |
Columns are period end dates